Pfizer raises 2025 profit forecast for second time in a row

Nov 4 (Reuters) - Pfizer PFE.N lifted its full-year profit forecast for the second time in a row on Tuesday, buoyed by strong demand for its blockbuster heart treatment and blood thinner.

The company said it expects adjusted earnings of $3.00 to $3.15 per share, up from its prior view of $2.90 to $3.10.

 (Reporting by Mrinalika Roy and Christy Santhosh in Bengaluru; Editing by Saumyadeb Chakrabarty)

 ((mrinalika.roy@thomsonreuters.com;))

Recent news on Metsera

See all news